Squarepoint
DXCM icon

Squarepoint’s DexCom DXCM Stock Holding History

Squarepoint’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$404K Sell
6,000
-200
-3% -$13.3K ﹤0.01% 3587
2026
Q1 		$389K Sell
6,200
-5,000
-45% -$348K ﹤0.01% 3508
2025
Q4 		$743K Sell
11,200
-27,100
-71% -$1.75M ﹤0.01% 2865
2025
Q3 		$2.58M Buy
38,300
+18,100
+90% +$1.43M ﹤0.01% 1896
2025
Q2 		$1.76M Sell
20,200
-33,400
-62% -$2.62M ﹤0.01% 2194
2025
Q1 		$3.66M Sell
53,600
-451,300
-89% -$36.8M ﹤0.01% 1631
2024
Q4 		$39.3M Buy
504,900
+141,600
+39% +$10.5M 0.04% 467
2024
Q3 		$24.4M Buy
363,300
+328,000
+929% +$26.9M 0.04% 508
2024
Q2 		$4M Buy
35,300
+17,200
+95% +$2.17M 0.01% 1529
2024
Q1 		$2.51M Sell
18,100
-11,400
-39% -$1.43M ﹤0.01% 1943
2023
Q4 		$3.66M Hold
29,500
– – 0.01% 1597
2023
Q3 		$2.75M Sell
29,500
-21,600
-42% -$2.43M 0.01% 1566
2023
Q2 		$6.57M Buy
51,100
+35,900
+236% +$4.34M 0.02% 921
2023
Q1 		$1.77M Buy
15,200
+1,800
+13% +$201K 0.01% 1499
2022
Q4 		$1.52M Sell
13,400
-4,300
-24% -$472K 0.01% 1532
2022
Q3 		$1.43M Buy
17,700
+3,800
+27% +$322K 0.01% 1536
2022
Q2 		$1.04M Buy
+13,900
New +$1.27M 0.01% 1580
2021
Q4 		– Sell
-3,600
Closed -$492K – 3239
2021
Q3 		$492K Sell
3,600
-22,000
-86% -$2.77M ﹤0.01% 1974
2021
Q2 		$2.73M Buy
25,600
+3,600
+16% +$346K 0.01% 1013
2021
Q1 		$1.98M Buy
+22,000
New +$2.07M 0.01% 1076

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Squarepoint's DXCM Position: Q2 2026 in Review

Squarepoint reduced its DexCom (DXCM) stake by 98% in Q2 2026, selling an estimated $75.7M and leaving 18,352 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #2738.

Squarepoint first reported a position in DXCM in Q2 2015 and has held it in 36 quarters since. The position peaked at $168M in Q4 2025. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Squarepoint held 18,352 shares of DexCom worth $1.24M as of Q2 2026.
  • Squarepoint sold 1,136,089 DexCom shares in Q2 2026, an estimated $75.7M.
  • DexCom made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #2738 holding.
  • Squarepoint first reported a position in DexCom in Q2 2015 and has held it in 36 quarters since.
  • Squarepoint's DexCom position peaked at $168M in Q4 2025.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.